Here are four quick facts:
1. Integra Lifesciences has a 52-week low of $44.11 and a 52-week high of $69.03.
2. The stock’s 50-day moving average is $63 and its 200-day moving average is $57.
3. The company has a market cap of $2.23 billion.
4. On average, the company has a rating of ‘buy’ and an average price target of $69.
More articles on devices:
MIS SI joint fusions: 5 key notes on the NASS coverage recommendation
Materialise partners with Consensus Orthopedics — 4 things to know
Mazor Robotics gets “buy” rating — 6 quick updates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
